Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion (2022)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bbr.2021.113555
- Subjects: ESTRÓGENOS; CANABINOIDES; MEMÓRIA; OVARIECTOMIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Behavioural Brain Research
- ISSN: 0166-4328
- Volume/Número/Paginação/Ano: v. 417, art. 113555, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CORRÊA, Márcio da Silveira et al. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion. Behavioural Brain Research, v. 417, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2021.113555. Acesso em: 03 dez. 2025. -
APA
Corrêa, M. da S., Freitas, B. S. de, Machado, G. D. B., Pires, V. N., Bromberg, E., Hallak, J. E. C., et al. (2022). Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion. Behavioural Brain Research, 417. doi:10.1016/j.bbr.2021.113555 -
NLM
Corrêa M da S, Freitas BS de, Machado GDB, Pires VN, Bromberg E, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion [Internet]. Behavioural Brain Research. 2022 ; 417[citado 2025 dez. 03 ] Available from: https://doi.org/10.1016/j.bbr.2021.113555 -
Vancouver
Corrêa M da S, Freitas BS de, Machado GDB, Pires VN, Bromberg E, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion [Internet]. Behavioural Brain Research. 2022 ; 417[citado 2025 dez. 03 ] Available from: https://doi.org/10.1016/j.bbr.2021.113555 - Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
Informações sobre o DOI: 10.1016/j.bbr.2021.113555 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
